May 14, 2026
1 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
GLP-1 receptor agonists may help improve outcomes among women with breast cancer and chronic cardiometabolic diseases, results of a retrospective cohort study suggest.Women with breast cancer and obesity who used GLP-1 medications exhibited significantly lower risks for all-cause mortality or recurrence than nonusers.
May 14, 2026
1 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Study on GLP-1s and Breast Cancer 'Too Good to Be True'?

GLP-1s and Hepatic Events; 'Shame, Taboo, Hygiene'; Treating Late-Onset IBD

Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss

The Oral GLP-1 Tracker: Wegovy pill total scripts down for first time

Weight loss drugs linked to surprising benefits for migraines and asthma

New daily pill may help people keep weight off after stopping jabs

GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition

Weight Gain & Cancer Risk; Steppin' Out After Surgery; Depression in Ovarian Cancer